메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology

[ 메디채널 김갑성 기자 ] The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted across Asia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the largest pivotal Phase III study to date in Asian patients with moderately to severely active ulcerative colitis. The study results showed that, during both the 12-week induction phase and the 40-week maintenance phase, etrasimod demonstrated statistically significant and clinically meaningf
- 김갑성 기자
- 2025-10-09 13:10
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

RIO DE JANEIRO, Oct. 9, 2025 -- Anbio Biotechnology participated in the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), an international gathering that brought together veterinarians, researchers, and industry representatives from more than 100 countries. The event provided a platform for Anbio to present its veterinary diagnostic portfolio and exchange views with partners across global markets. At WSAVA 2025, Anbio displayed five product lines: Fluorescence Immunoassay (FIA) Dry Chemistry Molecular Diagnostics Colloidal Gold Rapid Tests Dry Chem
- 김갑성 기자
- 2025-10-09 11:41
Yup, The Southeast Asia "Nubank", Raises $32 Million in C-1 Round, Bringing Total Equity Funding to over $100 million

SINGAPORE, Oct. 9, 2025 -- Southeast Asia's digital bank Yup has recently secured $32 million in their latest equity funding through its C-1 round, backed by US investment firms including Moore Strategic Ventures, Spice Expeditions and Platanus, with participation from other institutional investors and existing shareholders. The raise marks a pivotal moment for the company as it accelerates efforts to expand its customer base and edge closer to profitability. Since founded in 2021, Yup has demonstrated robust financial performance and consistent growth, cementing its position a
- 황정호 기자
- 2025-10-09 11:34
アジア初の「UBS House of Craft × Dior」展がシンガポールで開催

シンガポール、2025年10月9日 -- 2025年6月にニューヨークで好評を博した初開催に続き、「UBS House of Craft x Dior 」展が待望のアジアデビューを果たし、シンガポールで開催されます。更に規模が拡大された今回は、ディオールの80年以上にわたるレガシーとクラフトマンシップを称えたファッションおよび写真が展示されます。本展は、11月21日から23日まで、ホワイトストーン・ギャラリー内のニューアートミュージアム・シンガポールにて一般公開されます。クリスチャン・ディオールをはじめ、メゾンのレガシーを築き上げた6人のアーティスティック・ディレクター——イヴ・サン＝ローラン(Yves Saint Laurent)、マルク・ボアン(Marc Bohan)、ジャンフランコ・フェレ(Gianfranco Ferré)、ジョン・ガリアーノ(John Galliano)、ラフ・シモンズ(Raf Simons)、マリア・グラツィア・キウリ(Maria Grazia Chiuri)——の作品を通じて、ディオールの歴史を象徴する各時代の足跡を辿ることができます。また、キム・ジョーンズへのオマージュも併せて展示されます。見所は、高名なアーティストでありディオールの長年のコラボレーターであるブリジット・
- 김장윤(JASON KIM) 기자
- 2025-10-09 10:25
Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution

SINGAPORE, Oct. 9, 2025 -- Neopharma Technologies Ltd ("Neopharma"), a digital health company pioneering AI-driven Digital Drug and Impairment Testing, today announced the appointment of Mr. Joo Seng Wong to its Advisory Board. Mr. Wong will play a key role in strengthening Neopharma's institutional strategy, execution frameworks, and global commercialization roadmap as the company advances toward its planned NASDAQ listing. Institutional Credibility and Strategic Depth Mr. Wong is one of Singapore's most accomplished financial and technology lead
- 김갑성 기자
- 2025-10-09 09:58
Fosun International's S&P Global CSA Score Rises to 72, Retains Industry Lead

HONG KONG, Oct. 9, 2025 -- S&P Global recently released the 2025 Corporate Sustainability Assessment (CSA) score results for Fosun International Limited (HKEX stock code: 00656, "Fosun International" or "Fosun"). Fosun International's S&P Global CSA score has risen to 72 points, significantly outperforming the industry average and maintaining its leading position in the industry. In the 2024 S&P Global CSA, Fosun International achieved an excellent score of 70, ranking in the top 5% of its global industry peers. This year, Fosun International's sustained
- 황정호 기자
- 2025-10-09 09:25
Cohen & Steers Teams with DBS Bank to Provide Access to Cohen & Steers Diversified Real Assets Fund

SINGAPORE, Oct. 9, 2025 -- Cohen & Steers, Inc. (NYSE: CNS) announced it is teaming with DBS to provide access to the Cohen & Steers Diversified Real Assets Fund. The Diversified Real Assets Fund is designed to deliver attractive total return while maximizing real returns during inflationary environments. The strategy invests across four core real asset categories – global real estate, global natural resources, global listed infrastructure, and commodities – providing investors with broad diversification within the Real Assets category and inflation protection. Through t
- 황정호 기자
- 2025-10-09 09:00
QuestexのIHIF Asia、アジア太平洋地域ホテル市場に2,800億ドルの資本が流入、過去最高の取引実績を達成

2024年のイベントで成立した大型買収案件が、同会議が主要な投資プラットフォームとしての役割を果たしていることを改めて示す香港、2025年10月9日 -- QuestexのIHIF Asiaは、3日間にわたる集中的な取引交渉と戦略的議論を経て、アジア太平洋地域を代表するホテル投資フォーラムとしての地位を確固たるものにしました。本イベントには33か国から520名のシニア代表者が参加し、参加者の40％を占める投資家のAUMは2,800億ドルに達しました。これは2024年イベント時の2,100億ドルから33％の増加です。 Seibu Prince HotelsによるAce Hotel Group買収はブティック・ホテル業界の構造を変えた画期的な取引ですが、そのきっかけがIHIF Asia 2024での会合にあった事実が明らかになりました。これにより、本会議が取引の拠点として大きな役割を果たしていることが裏付けられています。これは、業界の統合と成長を推進する変革的な取引を促進する本フォーラムの独自の能力を示しています。多様な資金源が市場の成熟を示す本イベントの特筆すべき点は、中国・日本の投資家参加が大幅に増加したこと、そしてホスピタリティ業界が機関投資家にとって進化する魅力を持つことを示す新たな
- 황정호 기자
- 2025-10-09 09:00
코헨 앤드 스티어스, DBS 뱅크와 손잡고 코헨 앤드 스티어스 다각화 실물 자산 펀드에 접근할 수 있는 기회 제공

싱가포르, 2025년 10월 9일 -- 코헨 앤드 스티어스(Cohen & Steers, Inc. NYSE: CNS)는 DBS와 손을 잡고 코헨 앤드 스티어스 다각화 실물 자산 펀드에 접근할 기회를 제공할 것이라고 발표했다. 다각화 실물 자산 펀드는 인플레이션 기간에 실질 수익률을 극대화하는 동시에 매력적인 총 수익을 창출할 목적으로 설계된다. 글로벌 부동산, 글로벌 천연 자원, 글로벌 상장 인프라, 원자재 등 4가지 주요 실물 자산 카테고리를 대상으로 전략적인 투자가 이루어지기 때문에 실물 자산 카테고리 내에서 다각화를 통해 투자자들을 인플레이션에서 보호한다. 이번 협업으로 DBS 고객들은 코헨 앤드 스티어스가 수십 년 동안 실물 자산을 관리하면서 축적한 전문 지식에 접근할 수 있는 기회를 얻을 뿐만 아니라 여러 차례 시장 경기를 경험하면서 실적을 쌓은 투자 전문 팀에게 도움을 받을 수 있을 것으로 기대된다. DBS 뱅크(DBS Bank) 최고 투자 책임자인 허우 웨이 푹(Hou Wey Fook)에 따르면, "오늘날 변동성 및 지정학적 불확실성 증가로 양극화가 심해지면서 포트폴리오에서도 대체 투자와 실물
- 황정호 기자
- 2025-10-09 09:00
Aurum Gravis Expands Portfolio With Investment and Development of Vila Natura, A Rare Freehold Landed Project In Lentor

Backed by a S$23m closed-end fund comprising private and accredited investors Partners Redbrick Mortgage Advisory as both co-investor and mortgage advisory provider Yields 11 units comprising 10 semi-detached and 1 villa; to be launched in early 2026 with completion slated for end 2027 SINGAPORE, Oct. 9, 2025 -- Aurum Gravis, a Singapore-based firm focused on private real estate and alternative investments, is set to expand its portfolio of unique real estate developments with "Vila Natura" – a new freehold, project consisting of multiple landed properties in the emergi
- 황정호 기자
- 2025-10-09 08:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-10-15_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 15일 10시 10분